Learn how smart substance use treatment organizations are leveraging AI to improve client engagement, care quality, and provider satisfaction.
The substance use disorder field is in the middle of big changes. Small, mission-driven nonprofits — often running on limited resources — are now competing with large, capital-backed provider organizations entering markets funded by Medicaid and grants. Margins are tighter than ever, and the One Big Beautiful Bill Act will add new billing and documentation requirements that could strain already stretched teams.
In this environment, efficiency isn’t a “nice to have”— it’s survival. Organizations need ways to reduce administrative burden without sacrificing quality. That’s especially true in group therapy, where high-volume sessions create some of the heaviest documentation loads.
At the same time, substance use disorder programs depend on a unique workforce often made up of peers with lived experience. Alongside credentialed clinicians, they bring unmatched trust and empathy. The more time these teams can spend with clients, the stronger the care. Innovative technology can give them that time.
With cutting-edge technology like AI, organizations can protect their teams’ time, energy and confidence. This not only improves staff retention but also strengthens client outcomes. Even without the scale or capital of large competitors, mission-driven organizations can compete effectively thanks to purpose-built technology solutions.
In this 1-hour webinar hosted by National Council for Mental Wellbeing, Dr. Denny Morrison, Chief Clinical Officer at Eleos, and Philip Rutherford, Vice President of the Substance Use Continuum at National Council for Mental Wellbeing, explored AI use cases and opportunities in the substance use and addiction treatment space.
